Third Quarter Financial Report

15. Nov 2017 | 2 min read

Moss, 15 November 2017

Gentian Diagnostics AS announces its results for the third quarter. The highlights of the quarter include:

  • 66% growth in sales revenue compared to 3Q16, 16 % y/y
  • New patent protection received after end of period

Please find the report for the third quarter enclosed.

 

For further information, please contact:

Bård Sundrehagen CEO, Gentian Diagnostics
E-mail: Bard.sundrehagen@gentian.no
Cell Phone: +47 924 14 117

 
MeldingsID:  438711
 
 

You may also read


May 29, 2026 - Ole Sørlie

Mandatory notification of trade

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

May 13, 2026 - Ole Sørlie

Flaggemelding – Gentian Diagnostics ASA

Melding etter verdipapirhandelloven § 4-2 Oslo, 13 mai 2026 Vatne Capital AS, kontrollert av Runar Vatne, har..

May 13, 2026 - Ole Sørlie

Board resignation

Moss, 13 May 2026 Reference is made to the stock exchange release regarding Vatne Capital’s notification of..